Natural product-like synthetic libraries.
暂无分享,去创建一个
[1] A. Kozikowski,et al. Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity. , 2006, Journal of medicinal chemistry.
[2] Nathan T. Ross,et al. An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitors. , 2010, Journal of the American Chemical Society.
[3] Derek S. Tan,et al. Expanding the range of 'druggable' targets with natural product-based libraries: an academic perspective. , 2010, Current opinion in chemical biology.
[4] Stuart L. Schreiber,et al. Stereochemical and Skeletal Diversity Arising from Amino Propargylic Alcohols , 2010, Organic letters.
[5] Douglas A. Horton,et al. The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures , 2003 .
[6] P. Clemons,et al. Distinct Biological Network Properties between the Targets of Natural Products and Disease Genes , 2010, Journal of the American Chemical Society.
[7] Atul Kumar,et al. Natural product inspired diversity oriented synthesis of tetrahydroquinoline scaffolds as antitubercular agent. , 2011, ACS combinatorial science.
[8] Matthew E Welsch,et al. Privileged scaffolds for library design and drug discovery. , 2010, Current opinion in chemical biology.
[9] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[10] Stuart L Schreiber,et al. Syntheses of aminoalcohol-derived macrocycles leading to a small-molecule binder to and inhibitor of Sonic Hedgehog. , 2009, Bioorganic & medicinal chemistry letters.
[11] Stuart L Schreiber,et al. A planning strategy for diversity-oriented synthesis. , 2004, Angewandte Chemie.
[12] Sheo B. Singh,et al. Chapter 2:Chemical Space and the Difference Between Natural Products and Synthetics , 2009 .
[13] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[14] L. A. Marcaurelle,et al. Application of natural product-inspired diversity-oriented synthesis to drug discovery. , 2008, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.
[15] Bernd Becker,et al. Biological diversity from a structurally diverse library: systematically scanning conformational space using a pyranose scaffold. , 2010, Journal of Medicinal Chemistry.
[16] G. Rishton,et al. Molecular diversity in the context of leadlikeness: compound properties that enable effective biochemical screening. , 2008, Current opinion in chemical biology.
[17] Daniel Yohannes,et al. Diversity-oriented synthesis of a cytisine-inspired pyridone library leading to the discovery of novel inhibitors of Bcl-2. , 2009, Bioorganic & Medicinal Chemistry Letters.
[18] H. Waldmann,et al. Synthesis of Natural Product Inspired Compound Collections , 2009 .
[19] Adam Nelson,et al. Synthesis of Natural-Product-Like Molecules with Over Eighty Distinct Scaffolds** , 2008, Angewandte Chemie.
[20] Miklos Feher,et al. Property Distributions: Differences Between Drugs, Natural Products, and Molecules from Combinatorial Chemistry. , 2003 .
[21] Ricardo Macarron,et al. Enhancements of screening collections to address areas of unmet medical need: an industry perspective. , 2010, Current opinion in chemical biology.
[22] Stuart L Schreiber,et al. A synthesis strategy yielding skeletally diverse small molecules combinatorially. , 2004, Journal of the American Chemical Society.
[23] Heidi Ledford,et al. Complex synthesis yields breast-cancer therapy , 2010, Nature.
[24] N. Nakahata,et al. Furanodictine A and B: amino sugar analogues produced by cellular slime mold Dictyostelium discoideum showing neuronal differentiation activity. , 2001, The Journal of organic chemistry.
[25] Derek S. Tan,et al. The tert-butylsulfinamide lynchpin in transition-metal-mediated multiscaffold library synthesis. , 2010, Organic letters.
[26] Atul Kumar,et al. Diversity oriented synthesis of benzoxanthene and benzochromene libraries via one-pot, three-component reactions and their anti-proliferative activity. , 2010, Journal of combinatorial chemistry.
[27] R. Andersen,et al. Synthetic analogues of the microtubule-stabilizing sponge alkaloid ceratamine A are more active than the natural product. , 2010, Journal of medicinal chemistry.
[28] Stephen P. Hale,et al. The exploration of macrocycles for drug discovery — an underexploited structural class , 2008, Nature Reviews Drug Discovery.
[29] Zoya Titarenko,et al. BioCores: identification of a drug/natural product-based privileged structural motif for small-molecule lead discovery , 2010, Molecular Diversity.
[30] Youhong Hu,et al. Three-component one-pot approach to synthesize benzopyrano[4,3-d]pyrimidines. , 2010, Journal of combinatorial chemistry.
[31] C. Humblet,et al. Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.
[32] Herbert Waldmann,et al. Principles, implementation, and application of biology-oriented synthesis (BIOS) , 2010, Biological chemistry.
[33] Warren R. J. D. Galloway,et al. Drug discovery: A question of library design , 2011, Nature.
[34] E. Jacoby,et al. Chemogenomic strategies to expand the bioactive chemical space. , 2009, Current medicinal chemistry.
[35] Daniel Yohannes,et al. Diversity-oriented synthesis of a cytisine-inspired pyridone library leading to the discovery of novel inhibitors of Bcl-2. , 2009, Bioorganic & medicinal chemistry letters.
[36] Alan L Harvey,et al. Natural products in drug discovery. , 2008, Drug discovery today.
[37] S. Danishefsky,et al. Small molecule natural products in the discovery of therapeutic agents: the synthesis connection. , 2006, The Journal of organic chemistry.
[38] Sivaraman Dandapani,et al. Current strategies for diversity-oriented synthesis. , 2010, Current opinion in chemical biology.
[39] Stephen Hanessian,et al. Total synthesis of natural products, the "Chiron" approach , 1983 .
[40] J. Porco,et al. An approach to skeletal diversity using functional group pairing of multifunctional scaffolds. , 2007, Organic letters.
[41] Paul A. Wender,et al. Function‐Oriented Synthesis, Step Economy, and Drug Design , 2008 .
[42] T. Usui,et al. Novel and facile synthesis of furanodictines A and B based on transformation of 2-acetamido-2-deoxy-D-glucose into 3,6-anhydro hexofuranoses. , 2010, Carbohydrate research.
[43] David J Newman,et al. Natural products as sources of new drugs over the period 1981-2002. , 2003, Journal of natural products.
[44] Sangmi Oh,et al. Construction of a polyheterocyclic benzopyran library with diverse core skeletons through diversity-oriented synthesis pathway. , 2010, Journal of combinatorial chemistry.